DURHAM, N.C. & SEATTLE-- November 13, 2023--Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection. The...
Bioinformatics on the Brink (The Scientist)
News | 12. 20. 2004
Companies struggle to diversify after disappointing software sales sink the sector.
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.